C

Celon Pharma SA
WSE:CLN

Watchlist Manager
Celon Pharma SA
WSE:CLN
Watchlist
Price: 25.05 PLN 0.2% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Celon Pharma SA?
Write Note

Celon Pharma SA
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celon Pharma SA
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
C
Celon Pharma SA
WSE:CLN
Free Cash Flow
-zł11.5m
CAGR 3-Years
N/A
CAGR 5-Years
28%
CAGR 10-Years
N/A
M
Molecure SA
WSE:MOC
Free Cash Flow
-zł12m
CAGR 3-Years
N/A
CAGR 5-Years
-13%
CAGR 10-Years
N/A
C
Cannabis Poland SA
WSE:CBD
Free Cash Flow
-zł1.5m
CAGR 3-Years
-62%
CAGR 5-Years
-98%
CAGR 10-Years
N/A
No Stocks Found

Celon Pharma SA
Glance View

Market Cap
1.3B PLN
Industry
Pharmaceuticals

Celon Pharma SA is a pharmaceutical company, which engages in the research and manufacture of modern drugs. The firm focuses on research, development and production of generic drugs for cancer, neurological diseases, diabetes and other metabolic disorders treatment, among others. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir and Valzek, as well as inhalation powder, such as Salmex. The firm's research center develops pharmaceuticals within a number of therapeutic areas, including oncology, neurology, as well as inflammatory and metabolic diseases. The firm is a subsidiary of Glatton sp z o o.

CLN Intrinsic Value
9.71 PLN
Overvaluation 61%
Intrinsic Value
Price
C

See Also

What is Celon Pharma SA's Free Cash Flow?
Free Cash Flow
-11.5m PLN

Based on the financial report for Jun 30, 2024, Celon Pharma SA's Free Cash Flow amounts to -11.5m PLN.

What is Celon Pharma SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
28%

Over the last year, the Free Cash Flow growth was 78%.

Back to Top